Desjardins Global Asset Management Inc. Jazz Pharmaceuticals PLC Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 15,793 shares of JAZZ stock, worth $1.64 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
15,793Holding current value
$1.64 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
513Shares Held
57MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$732 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$668 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$255 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$246 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$155 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.49B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...